CTRI/2023/01/048730尚未招募3 期
Assessment of Cardiovascular Outcomes with Addition of Sacubitril-Valsartan in Dialysis Patients with Systolic and Diastolic Dysfunction - A Pilot Study
IQRAA Hospital, Calicut0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Chronic kidney disease stage 5, on maintanence dialysis
- •-Systolic dysfunction with EF <= 40% or diastolic dysfunction as defined by ECHO parameters
- •-18-75years
- •-3/week HD or nocturnal HD or frequent HD with optimised UF (adequacy as assessed as per discretion of nephrologist)
排除标准
- •-Age < 18 years and > 75 years
- •- Non-compliant with medications/ dialysis (assessed as per discretion of nephrologist), Interdialytic weight gain > 3.5 litres
- •-Refractory hyperkalemia defined at pre-dialyisis potassium > 6mmol/L
- •-Clinical significant/ life-threatening Infection, requiring hospitalization in last 3 months
- •-Malignancy
- •-Pregnancy
研究者
相似试验
尚未招募
不适用
Clinical outcomes and cardiovascular responses to High Intensity Interval Training versus Moderate Intensity Continuous Training in Heart Failure Patients: A randomized, controlled trial.Cardiovascular - Other cardiovascular diseasesPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationSystolic Heart FailureACTRN12612000511831niversity of New England48
进行中（未招募）
不适用
Cardiovascular evaluation Exercise in patients with Sjogren's SyndromeM35.0Sjogren's syndromeRBR-3v3zmdniversidade Federal de São Paulo
进行中（未招募）
不适用
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusType 2 diabetes patients with a recent acute coronary syndrome (ACS) eventMedDRA version: 15.1Level: PTClassification code 10007649Term: Cardiovascular disorderSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-012269-71-SEF. Hoffmann-La Roche Ltd.7,000
进行中（未招募）
不适用
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusType 2 diabetes patients with a recent acute coronary syndrome (ACS) eventMedDRA version: 14.1Level: PTClassification code 10007649Term: Cardiovascular disorderSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-012269-71-CZF. Hoffmann-La Roche Ltd.7,000
进行中（未招募）
不适用
Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D)Type 2 diabetes patients with a recent acute coronary syndrome (ACS) eventMedDRA version: 12.0Level: LLTClassification code 10007649Term: Cardiovascular disorderEUCTR2009-012269-71-HUF. Hoffmann-La Roche Ltd.6,000